Published on

Published in: Business, Technology


  2. 2. HISTORICAL PERSPECTIVES2Jenner 1796 : Cowpox• 1800’s Compulsorychildhood vaccination• 1930’s Last natural UKcase• 1940’s last natural US case• 1958 WHO program• October 1977: Last case(Somalia)
  3. 3. ImmunizationImmunisation is the process of conferringincreased resistance (or decreasedsusceptibility) to infection
  4. 4. Active Vs Passive Immunization Active immunization Can be achieved through natural infection by amicroorganism or it can be acquired artificiallythrough the administration of vaccines Antibodies produced in response to aninfection e.g. natural measles virus Antibodies produced in response to a vaccine(live, inactivated or toxoid) Individuals make their own antibodies
  5. 5. Active Vs Passive ImmunizationPassive Immunity Individual gains antibodies from another who has produced them Transfer of maternal antibodies through theplacenta or in breast milk Administration of antibodies collected fromactively immune humans or animals e.g.varicella zoster immunoglobulin VZIG
  6. 6. 6
  7. 7. What is a Vaccine? A preparation of the causative agent of adisease, specially treated for use in vaccination,in order to induce or increase immunity Typically contains an agent that resembles adisease-causing microorganism, and is oftenmade from Weakened or killed microorganismsor subunits (purified protein subunits,polysaccharides).
  8. 8. What is a Vaccine? Based on 2 key elements of adaptiveimmunity:Specificity and Memory Stimulation of an individual’s ownimmune system to produce antibodies byadministration of a vaccine
  9. 9. Active Immunization throughdesigning Vaccines9Before designing any vaccine, two thingsshould be considered: Activation of humoral and cell mediatedimmune response shown by a particularantigen Development of immunologic memoryby the particular antigen
  10. 10. The Mechanism of a Vaccine In an ideal scenario,whenever a vaccine is firstadministered, it isphagocytized by an antigenpresenting cell. Recent research suggestthat it is particularlyimportant that the vaccinebe taken up by a dendriticcell. This is because dendriticcells play a key role inactivating T cells, whichbecome helper T cells
  11. 11.  From there, theactivated Th cells goeson to activate matureB-cells. These activated B-cellsdivides into two celltypes, antibody-producing plasma cellsand, most importantly,memory B cells.The Mechanism of aVaccine
  12. 12. Importance of Secondary ImmuneResponse During the secondary immune response, the bodymounts a quicker, more robust attack on thepathogen. Thus, the pathogen is cleared from the bodybefore it has the chance to cause an infection.
  13. 13. Adjuvants An adjuvant is achemical substance thatcan be added to avaccine in order toenhance the immuneresponse to the vaccine. There are three types ofadjuvants.
  14. 14. AdjuantsAluminum Hydroxide and Aluminum Phosphate (Alum) Alum is an inorganic salt thatbinds to proteins and causesthem to precipitate. Whenever the alum/vaccinecomplex is injected into thebody, it slowly dissolves,releasing the vaccine. Bacterial extracts can be added,which enhances the immuneresponse. Alum is the only adjuvantapproved for use in humans.
  15. 15. AdjuantsFreund’s Adjuvant In Freund’s adjuvant, thevaccine is suspended in oildroplets. When injected into the body,the vaccine slowly diffuses outof the oil drop. Bacterial antigens can be addedin order to enhance the immuneresponse. Not used in humans because ofrisk of severe inflammation.
  16. 16. Routes of Administration There are three different routesof administration: Intradermal administration. Three types are intravenous,intramuscular, andsubcutaneous. Oral administration. Vaccine is usually given inliquid form. Foods, such as tomatoes, havebeen engineered to produce avaccine. Intranasal administration.
  17. 17. Boosters For most vaccines, theimmunity against a particularpathogen has a tendencyto wear off over time. In this case, a periodic“booster” administration mustbe given in order tostrengthen and lengthenthe duration of immunity.
  18. 18. Active immunization byartificial means can be achievedby:18Attenuated organisms (avirulent)Inactivated organisms (killed)Purified microbial macromoleculesCloned microbial antigensSynthetic peptidesAnti-idiotype antibodiesMultivalent complexes
  19. 19. Types of Vaccines19 Live-attenuated Inactivated Toxoid Subunit Conjugate Combination Innovative Edible
  20. 20. 20
  21. 21. Live-attenuated Vaccine21Oral Polio Vaccine (Sabin)MMR (measles, mumps and rubella)VaricellaBCGRotavirusOral typhoid etc.
  22. 22. Advantages of Attenuated Vaccines22••Raises immune response to all protectiveantigens.• More durable immunity• Low cost• Quick immunity in majority of vaccinees• In case of polio and adeno vaccines, easyadministration• Easy transport in field•Disadvantages of Attenuated VaccinesMutation; reversion to virulence (often frequent)
  23. 23. The Milestone23
  24. 24. Inactivated vaccines The bacteria orvirus is completelykilled using achemical, usuallyformaldehydeExamples hepatitis A hepatitis B poliovirus (Salk) influenza24
  25. 25. 25
  26. 26. 26Advantages of inactivated vaccinesGives sufficient humoral immunity if boostersgiven• No mutation or reversioDisadvantages of inactivated vaccines• Many vaccinees do not raise immunity• Boosters needed• No local immunity (important)• Higher cost• Shortage of monkeys (polio)• Failure in inactivation and immunizationwith virulent virus
  27. 27. Vaccines from whole organismsMany of the currently used vaccines to dateconsist of inactivated or live but attenuatedbacterial cells or virus particlesBacterial cellsPlague , pertusis, choleraInactivatedTuberculosisAttenuated BCGViral particalsInfluenza , rubella virus InactivatedPolio (Salk) InactivatedPolio (Sabin) AttenuatedYellow fever Attenuated
  28. 28. Toxoid Vaccines Pathogenic toxin ismodified toharmless toxoid Examples ofToxoid-basedvaccines includetetanus anddiphtheria28
  29. 29. Attenuated Vs Inactivated VaccinesAttenuated InactivatedMethod of production:Virulent strain grown under Virulence is inactivatedby adverse culture conditions chemical treatment orby prolonged growth inunnatural radiationhost or passage throughdifferent unnatural hostsRequirement of booster dose:Generally single booster dose Multiple booster dosesis required are requiredStability:Less stable More stable andresistantto natural temperature
  30. 30. Attenuated Vs Inactivated VaccinesType of host Immune responses:Produce both cell mediated Mainly producesand humoral immune response humoral responseTendency to revert:May revert to original virulent Does not revert tovirulent strain by recombination virulent formwith wild type strain or reversemutationAttenuated Inactivated
  31. 31. Subunit Vaccines• Risks associated with attenuated orkilled whole vaccines can be avoided bysubunit vaccines• Consist of specific, purifiedmacromolecules derived pathogens31
  32. 32. Subunit Vaccines32 Protein subunit (toxoid)- diphteria, tetanus Bacterial polysaccharide- S. pneumoniae, Nisseriameningitidis Viral glycoproteins- Herpes simplex virus glycoprotein D Synthetic peptides produced from active epitopes ofantigen are used as vaccines.Synthetic peptide vaccines for HIV, influenza, diphtheriatoxin, hepatitis B virus and malaria parasite are currentlybeing evaluated for their efficacyNot very successful as peptides are not as immunogenic asproteins
  33. 33. Subunit Vaccines Recombinant pathogen proteins-Gene coding any immunogenic protein cloned byrecombinant DNA technologyE.g. hepatitis Bs Ag gene cloned in yeast
  34. 34. 34
  35. 35. Recombinant Vectors VaccinesAttenuated viruses and bacteria serve asvectorsGenes encoding major antigens of virulentpathogens can be introduced into theseWide range of organisms used as vectors:vaccinia virus,attenuated polio virus,canary pox virus, adenovirus,BCG strain of Mycobacterium bovis
  36. 36. The Hierarchy of VaccinesFirst generation vaccines are whole-organism vaccines– either live and weakened, or killed forms.The so-called second generation vaccines are subunitvaccines, consisting of defined protein antigens (suchas tetanus or diphtheria toxoid)or recombinant protein components (such as thehepatitis B surface antigen).DNA vaccines are third generation vaccines
  37. 37. DNA Vaccines - The Third GenerationVaccines37• 1796 Jenner: wild type animal-adapted virus• 1800’s Pasteur: Attenuated virus• 1996 DNA vaccines
  38. 38. DNA VaccinesMade up of plasmid that has been geneticallyengineered to produce one or two specific proteins(antigens) from a pathogen.The vaccine DNA is injected into the cells of thebody, where the "inner machinery" of the host cells"reads" the DNA and converts it into pathogenicproteins.Because these proteins are recognised as foreign,when they are processed by the host cells anddisplayed on their surface, the immune system isalerted, which then triggers a range of immune
  39. 39. Applications of DNAVaccinesDNA vaccines are in their early phaseof clinical trials.There are no DNA vaccines in marketat present.At present human trials are under wayfor malaria, influenza, AIDS, Ebola andHerpes.
  40. 40. Advantages of DNA Vaccines40Plasmids are easily manufactured in large amountsDNA is very stableDNA resists temperature extremes so storage andtransport are straight forward. Refrigeration isnot requiredStable for storageElicit both humoral & cell mediated immunityFocused on Antigen of interestLong term immunity
  41. 41. Disadvantages of DNA VaccinesLimited to protein immunogen onlyExtended immunostimulation leads tochronic inflammationPlasmid used is resistance to antibiotics forselection. Can raise the resistance to sameantibiotic in the host
  42. 42. Conjugate Vaccines Certain bacteria havepolysaccharide outercoats that are poorlyimmunogenic (Tindependent Ags) By linking these outercoats to proteins (e.g.toxiods), the immunesystem can be led torecognize thepolysaccharide as if itwere a protein antigen Haemophilus influenzaetype B vaccine42
  43. 43. Combination vaccines43 DTP - Combination vaccine prevents three diseasesin one shotDiphtheria, Tetanus (lockjaw), Pertussis (whoopingcough) MMRMeasles, Mumps, Rubella
  44. 44. Edible vaccines44 Antigens or antibodies expressed in plants Oral administration Cheaper Exhibit good genetic stability Do not require special storage conditions Since syringes and needles are not used,chances of infection are also less
  45. 45. 45
  46. 46. Anti-idiotype vaccines Idiotype- unique amino acid sequence of Vdomain of a given Ab – Ag binding site as wellas antigenic determinantGeneration of an effective immuneresponse to a dangerous pathogenwithout exposing the individual to anyform of pathogen as vaccineIt is known as anti-idiotype antibodiesVaccines of this type have been developedagainst pathogens of viral, bacterial orparasitic type
  47. 47. 47antibodyAnti-idiotype vaccineepitopeAntibody withepitope bindingsiteVirusAnti-idiotype vaccinesAnti-idiotype vaccines
  48. 48. 48antibodyMake antibody againstantibody idiotypeAnti-idiotypeantibodyAnti-idiotypeantibody mimicsthe epitopeAnti-idiotype vaccines
  49. 49. 49Anti-anti-idiotypeantibodyAnti-idiotype antibodyUse anti-idiotype antibodyas injectable vaccineAntibody to anti-idiotypeantibodyBinds andneutralizes virusAnti-idiotypeantibodyAnti-anti-idiotypeantibodyAnti-anti-idiotypeantibodyUse as vaccine
  50. 50. VACCINESThe never endingjourney……
  51. 51. Why arent vaccines available for alldiseases ?51 The procedure for developing a vaccine is time taking and veryexpensive Vaccines are prioritized in following order: Vaccines that fight diseases that cause the most deaths anddamage, like meningitis Vaccines that prevent severe diseases like measles and influenza Vaccines, like the one for rotavirus, that prevent significantsuffering Companies must get significant return on investment Some viruses mutate so quickly that traditional vaccines areineffective. A prime example is the HIV/AIDS virus